$IBOC
INTERNATIONAL BANCSHARES CORP

2023 Q2 Form 10-Q Financial Statement

#000155837023008049 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $198.1M $188.1M
YoY Change 80.8% 95.11%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.408M $5.466M
YoY Change -0.86% -0.16%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $31.67M $22.96M
YoY Change 373.87% 259.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $127.8M $128.9M
YoY Change 73.53% 89.72%
Income Tax $27.32M $27.29M
% Of Pretax Income 21.38% 21.16%
Net Earnings $100.5M $101.6M
YoY Change 73.34% 90.01%
Net Earnings / Revenue 50.72% 54.02%
Basic Earnings Per Share $1.62 $1.64
Diluted Earnings Per Share $1.62 $1.63
COMMON SHARES
Basic Shares Outstanding 62.11M 62.14M
Diluted Shares Outstanding 62.21M 62.28M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.025B $1.195B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $430.6M $430.4M
YoY Change -1.05% -1.76%
Goodwill $282.5M $282.5M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $14.85B $15.13B
YoY Change -8.7% -6.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $441.8M $383.5M
YoY Change -13.93% -21.75%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $441.8M $383.5M
YoY Change -13.93% -21.75%
LONG-TERM LIABILITIES
Long-Term Debt $108.9M $134.6M
YoY Change -19.14% 0.0%
Other Long-Term Liabilities $166.0M $168.7M
YoY Change 13.19% 27.0%
Total Long-Term Liabilities $274.9M $303.4M
YoY Change -2.28% 13.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $441.8M $383.5M
Total Long-Term Liabilities $274.9M $303.4M
Total Liabilities $12.66B $12.98B
YoY Change -10.66% -7.22%
SHAREHOLDERS EQUITY
Retained Earnings $2.859B $2.758B
YoY Change 12.36% 10.94%
Common Stock $96.43M $96.42M
YoY Change 0.07% 0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.192B $2.156B
YoY Change
Total Liabilities & Shareholders Equity $14.85B $15.13B
YoY Change -8.7% -6.21%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $100.5M $101.6M
YoY Change 73.34% 90.01%
Depreciation, Depletion And Amortization $5.408M $5.466M
YoY Change -0.86% -0.16%
Cash From Operating Activities $85.25M $142.7M
YoY Change -3.44% 80.4%
INVESTING ACTIVITIES
Capital Expenditures $5.595M $4.290M
YoY Change -191.95% 72.57%
Acquisitions
YoY Change
Other Investing Activities $66.89M -$564.0M
YoY Change -126.98% 2228.3%
Cash From Investing Activities $61.30M -$568.3M
YoY Change -124.13% 2027.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -316.1M -467.1M
YoY Change -335.53% -350.34%
NET CHANGE
Cash From Operating Activities 85.25M 142.7M
Cash From Investing Activities 61.30M -568.3M
Cash From Financing Activities -316.1M -467.1M
Net Change In Cash -169.6M -892.7M
YoY Change 438.62% -473.57%
FREE CASH FLOW
Cash From Operating Activities $85.25M $142.7M
Capital Expenditures $5.595M $4.290M
Free Cash Flow $79.65M $138.4M
YoY Change -15.59% 80.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000315709
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-09439
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
INTERNATIONAL BANCSHARES CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2157138
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1200 San Bernardo Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Laredo
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78042-1359
CY2023Q1 dei City Area Code
CityAreaCode
956
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
722-7611
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $1.00 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
IBOC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62114576
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1195048000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2087724000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2023Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
3400000
CY2022Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
3400000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5397131000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5018996000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4859818000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4417796000
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
5392000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
5358000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
4868610000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
4426554000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7531773000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7430603000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
133557000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
125972000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
7398216000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
7304631000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
430436000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
431612000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
49020000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
45787000
CY2023Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
362105000
CY2022Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
358910000
CY2023Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
299379000
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
300589000
CY2023Q1 us-gaap Goodwill
Goodwill
282532000
CY2022Q4 us-gaap Goodwill
Goodwill
282532000
CY2023Q1 us-gaap Other Assets
OtherAssets
249605000
CY2022Q4 us-gaap Other Assets
OtherAssets
263137000
CY2023Q1 us-gaap Assets
Assets
15134951000
CY2022Q4 us-gaap Assets
Assets
15501476000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
5548745000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
5846055000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
4587639000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
4745768000
CY2023Q1 us-gaap Time Deposits
TimeDeposits
2144395000
CY2022Q4 us-gaap Time Deposits
TimeDeposits
2068184000
CY2023Q1 us-gaap Deposits
Deposits
12280779000
CY2022Q4 us-gaap Deposits
Deposits
12660007000
CY2023Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
383502000
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
431191000
CY2023Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
10895000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
10944000
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2022Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
168725000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
219933000
CY2023Q1 us-gaap Liabilities
Liabilities
12978543000
CY2022Q4 us-gaap Liabilities
Liabilities
13456717000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96423993
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96420456
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
96424000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
96420000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154244000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154061000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2758059000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2695567000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-420491000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-470497000
CY2023Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2588236000
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2475551000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
34303617
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
34278617
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
431828000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
430792000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2156408000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2044759000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15134951000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15501476000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
142270000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
81488000
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
29809000
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
13190000
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1578000
CY2022Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
350000
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
14492000
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1404000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
188149000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
96432000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101643000
CY2023Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
11694000
CY2022Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
1101000
CY2023Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6829000
CY2022Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
2504000
CY2023Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
2142000
CY2022Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
184000
CY2023Q1 us-gaap Interest Expense Other Domestic Deposits
InterestExpenseOtherDomesticDeposits
71000
CY2022Q1 us-gaap Interest Expense Other Domestic Deposits
InterestExpenseOtherDomesticDeposits
1888000
CY2023Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
2228000
CY2022Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
709000
CY2023Q1 us-gaap Interest Expense
InterestExpense
22964000
CY2022Q1 us-gaap Interest Expense
InterestExpense
6386000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
165185000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
90046000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
8587000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1481000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
156598000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
88565000
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
2955000
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
2882000
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
3845000
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
9092000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
40362000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
43512000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
32859000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
31119000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
6326000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
6272000
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
5466000
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
5475000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
3590000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
2318000
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
4138000
CY2022Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
1057000
CY2023Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
1745000
CY2022Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
408000
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
1264000
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
1440000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4969000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4177000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
11162000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
12668000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
68029000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
64118000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
128931000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
67959000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27288000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14466000
CY2022Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
777000
CY2023Q1 iboc Accretion Of Discounts Investments
AccretionOfDiscountsInvestments
589000
CY2022Q1 iboc Accretion Of Discounts Investments
AccretionOfDiscountsInvestments
235000
CY2023Q1 iboc Amortization Of Investment Securities Premiums
AmortizationOfInvestmentSecuritiesPremiums
1817000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
53493000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62142264
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63352240
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.64
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62282328
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63498268
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101643000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
53493000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
13293000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-46029000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
50006000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-173156000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
50006000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-173156000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
151649000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-119663000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2044759000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101643000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.63
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
39151000
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
25000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1036000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
85000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
102000
CY2023Q1 iboc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Net Of Reclassification Adjustment
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringNetOfReclassificationAdjustment
50006000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2156408000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2308481000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
53493000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
38026000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
83066
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3380000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
146000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
121000
CY2022Q1 iboc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Net Of Reclassification Adjustment
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringNetOfReclassificationAdjustment
-173156000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2147679000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
101643000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
53493000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
8587000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1481000
CY2023Q1 us-gaap Other Real Estate Covered Valuation Adjustments
OtherRealEstateCoveredValuationAdjustments
-250000
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
5466000
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
5475000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2991000
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
2372000
CY2022Q1 iboc Amortization Of Investment Securities Premiums
AmortizationOfInvestmentSecuritiesPremiums
5262000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
34000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-269000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
102000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
121000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
802000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2474000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1841000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
80000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3233000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3038000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1277000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4455000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
32419000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
20810000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
142690000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
79097000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
1200000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
1075000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
450000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
595184000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
362746000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS
134171000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS
207302000
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
102525000
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-159246000
CY2023Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
9935000
CY2022Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
42043000
CY2023Q1 iboc Distributions From Other Investments
DistributionsFromOtherInvestments
5124000
CY2022Q1 iboc Distributions From Other Investments
DistributionsFromOtherInvestments
1583000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4290000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2486000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6461000
CY2023Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
2691000
CY2022Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
4898000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-568298000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26710000
CY2023Q1 iboc Increase Decrease In Noninterest Bearing Demand Deposits
IncreaseDecreaseInNoninterestBearingDemandDeposits
-297310000
CY2022Q1 iboc Increase Decrease In Noninterest Bearing Demand Deposits
IncreaseDecreaseInNoninterestBearingDemandDeposits
198680000
CY2023Q1 iboc Increase Decrease In Saving And Interest Bearing Demand Deposits
IncreaseDecreaseInSavingAndInterestBearingDemandDeposits
-158129000
CY2022Q1 iboc Increase Decrease In Saving And Interest Bearing Demand Deposits
IncreaseDecreaseInSavingAndInterestBearingDemandDeposits
-28897000
CY2023Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
76211000
CY2022Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
7676000
CY2023Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-47689000
CY2022Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
50419000
CY2023Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
-49000
CY2022Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
-48000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1036000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3380000
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
85000
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
146000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39151000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
38026000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-467068000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
186570000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-892676000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
238957000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2087724000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3209242000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1195048000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3448199000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
19731000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
6297000
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
353000
CY2022Q1 iboc Transfer From Bank Premise And Equipment To Other Assets
TransferFromBankPremiseAndEquipmentToOtherAssets
2476000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 iboc Number Of Active Operating Subsidiaries
NumberOfActiveOperatingSubsidiaries
5
CY2023Q1 iboc Impaired Financing Receivable Recorded Investment Fair Value Disclosure
ImpairedFinancingReceivableRecordedInvestmentFairValueDisclosure
51306000
CY2023Q1 iboc Impaired Commercial Collateral Financing Receivable Appraisals To Determine Fair Value
ImpairedCommercialCollateralFinancingReceivableAppraisalsToDetermineFairValue
0
CY2023Q1 iboc Impaired Collateral Dependent Commercial Loans With Internal Evaluation Completed Within Last Twelve Months
ImpairedCollateralDependentCommercialLoansWithInternalEvaluationCompletedWithinLastTwelveMonths
51306000
CY2022Q4 iboc Impaired Financing Receivable Recorded Investment Fair Value Disclosure
ImpairedFinancingReceivableRecordedInvestmentFairValueDisclosure
51326000
CY2022Q4 iboc Impaired Commercial Collateral Financing Receivable Appraisals To Determine Fair Value
ImpairedCommercialCollateralFinancingReceivableAppraisalsToDetermineFairValue
0
CY2022Q4 iboc Impaired Collateral Dependent Commercial Loans With Internal Evaluation Completed Within Last Twelve Months
ImpairedCollateralDependentCommercialLoansWithInternalEvaluationCompletedWithinLastTwelveMonths
51326000
CY2023Q1 iboc Allowance For Loan And Lease Losses Period Increase Decrease Loans Transferred To Other Real Estate Owned
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecreaseLoansTransferredToOtherRealEstateOwned
0
CY2022 iboc Allowance For Loan And Lease Losses Period Increase Decrease Loans Transferred To Other Real Estate Owned
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecreaseLoansTransferredToOtherRealEstateOwned
2000
CY2023Q1 iboc Allowance For Loan Lease Losses Write Offs Prior To Foreclosure
AllowanceForLoanLeaseLossesWriteOffsPriorToForeclosure
250000
CY2022 iboc Allowance For Loan Lease Losses Write Offs Prior To Foreclosure
AllowanceForLoanLeaseLossesWriteOffsPriorToForeclosure
1627000
CY2023Q1 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Losses
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedLosses
544087000
CY2022Q4 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
3400000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2022Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
3400000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7531773000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7430603000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
125972000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2033000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1031000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
1002000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
8587000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
133557000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
110374000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2329000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
701000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
1628000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1481000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
110227000
CY2023Q1 iboc Financing Receivable Evaluated For Impairment Individually
FinancingReceivableEvaluatedForImpairmentIndividually
51809000
CY2023Q1 iboc Financing Receivable Individually Evaluated For Impairment Allowance For Credit Losses
FinancingReceivableIndividuallyEvaluatedForImpairmentAllowanceForCreditLosses
3445000
CY2023Q1 iboc Financing Receivable Evaluated For Impairment Collectively
FinancingReceivableEvaluatedForImpairmentCollectively
7479964000
CY2023Q1 iboc Financing Receivable Collectively Evaluated For Impairment Allowance For Credit Losses
FinancingReceivableCollectivelyEvaluatedForImpairmentAllowanceForCreditLosses
130112000
CY2022Q4 iboc Financing Receivable Evaluated For Impairment Individually
FinancingReceivableEvaluatedForImpairmentIndividually
51830000
CY2022Q4 iboc Financing Receivable Individually Evaluated For Impairment Allowance For Credit Losses
FinancingReceivableIndividuallyEvaluatedForImpairmentAllowanceForCreditLosses
2445000
CY2022Q4 iboc Financing Receivable Evaluated For Impairment Collectively
FinancingReceivableEvaluatedForImpairmentCollectively
7378773000
CY2022Q4 iboc Financing Receivable Collectively Evaluated For Impairment Allowance For Credit Losses
FinancingReceivableCollectivelyEvaluatedForImpairmentAllowanceForCreditLosses
123527000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
51632000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
51648000
CY2022Q4 iboc Equity Securities And Available For Sale Debt Securities Amortized Cost Basis
EquitySecuritiesAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
5018996000
CY2022Q4 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Gains
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedGains
4072000
CY2022Q4 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Losses
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedLosses
605272000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
511853000
CY2022Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3213000
CY2023Q1 us-gaap Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
P90D
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
5629000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7531773000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
6132000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7430603000
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
1072045000
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
2703074000
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
1773923000
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
828049000
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
473803000
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
680879000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7531773000
CY2022Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
3048975000
CY2022Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
2081483000
CY2022Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
988625000
CY2022Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
543277000
CY2022Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
468848000
CY2022Q4 iboc Financing Receivable Originated More Than Six Years Before Current Fiscal Year
FinancingReceivableOriginatedMoreThanSixYearsBeforeCurrentFiscalYear
299395000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7430603000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
489250
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
39.35
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
5750
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
39.33
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
483500
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
39.35
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P9Y6M
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1680000
CY2023Q1 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
3400000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2023Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
3400000
CY2023Q1 iboc Equity Securities And Available For Sale Debt Securities Amortized Cost Basis
EquitySecuritiesAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
5397131000
CY2023Q1 iboc Equity Securities And Available For Sale Debt Securities Gross Unrealized Gains
EquitySecuritiesAndAvailableForSaleDebtSecuritiesGrossUnrealizedGains
6774000
CY2023Q1 us-gaap Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost
HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost
1075000
CY2023Q1 us-gaap Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value
HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
1075000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
49967000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
49925000
CY2023Q1 us-gaap Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost
HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost
2325000
CY2023Q1 us-gaap Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value
HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
2325000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
440000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
440000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
162507000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
162224000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
5184217000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
4647229000
CY2023Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
3400000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3400000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5397131000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4859818000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
450000
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
0
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
0
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2022Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
0
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1593958000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
45986000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
2969348000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
498101000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
4563306000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
544087000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1526071000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
93419000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
2566975000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
4093046000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
605272000
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
5392000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
5358000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
34000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
34000
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-269000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-269000
CY2023Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
10895000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
10944000
CY2023Q1 iboc Number Of Statutory Business Trusts Issuing Preferred Securities
NumberOfStatutoryBusinessTrustsIssuingPreferredSecurities
5
CY2023Q1 iboc Number Of Statutory Business Trusts Issuing Preferred Securities
NumberOfStatutoryBusinessTrustsIssuingPreferredSecurities
5
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2022Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2023Q1 iboc Maximum Number Of Consecutive Quarterly Periods Available For Deferral Of Payment Of Interest
MaximumNumberOfConsecutiveQuarterlyPeriodsAvailableForDeferralOfPaymentOfInterest
20
CY2023Q1 iboc Maximum Percentage Of Capital Securities Issued By Trust Qualifying As Tier One Capital
MaximumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
0.25
CY2023Q1 iboc Minimum Percentage Of Capital Securities Issued By Trust Qualifying As Tier Two Capital
MinimumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierTwoCapital
0.25
CY2023Q1 iboc Capital Securities Issued By Trust Qualifying As Tier One Capital
CapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
134642000
CY2022Q4 iboc Capital Securities Issued By Trust Qualifying As Tier One Capital
CapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
134642000
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.63
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.60
CY2009Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40000000
CY2009Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P12M
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
124000000
CY2022Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P12M
CY2022Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
13615730
CY2022Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
411099000
CY2023Q1 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.2043
CY2022Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.2021
CY2023Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1561
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1459
CY2023Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.2137
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.2104
CY2023Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.2260
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.2222
CY2023Q1 iboc Maximum Percentage Of Capital Securities Issued By Trust Qualifying As Tier One Capital
MaximumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierOneCapital
0.25
CY2023Q1 iboc Minimum Percentage Of Capital Securities Issued By Trust Qualifying As Tier Two Capital
MinimumPercentageOfCapitalSecuritiesIssuedByTrustQualifyingAsTierTwoCapital
0.25
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
134642000

Files In Submission

Name View Source Status
0001558370-23-008049-index-headers.html Edgar Link pending
0001558370-23-008049-index.html Edgar Link pending
0001558370-23-008049.txt Edgar Link pending
R44.htm Edgar Link pending
0001558370-23-008049-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iboc-20230331.xsd Edgar Link pending
iboc-20230331x10q.htm Edgar Link pending
iboc-20230331xex31da.htm Edgar Link pending
iboc-20230331xex31db.htm Edgar Link pending
iboc-20230331xex32da.htm Edgar Link pending
iboc-20230331xex32db.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
iboc-20230331_cal.xml Edgar Link unprocessable
iboc-20230331_pre.xml Edgar Link unprocessable
iboc-20230331x10q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
iboc-20230331_def.xml Edgar Link unprocessable
iboc-20230331_lab.xml Edgar Link unprocessable